Facebook Pixel Code
image of child
Cancer Genetics Program

Appendix 2

  1. Nichols KE, Malkin D, Garber JE, Fraumeni JF Jr, Li FP: Germ-line p53 mutations predispose to a wide spectrum of early-onset cancers. Cancer Epidemology, Biomarkers and Prevention 2001: 10(2): pp 83-87. [Res] CPA
  2. Portwine C, Chilton-MacNeill S, Brown C, Sexsmith E, McLaughlin J, Malkin D: Absence of germline and somatic p53 alterations in children with sporadic brain tumors. Journal of Neuro-Oncology 2001: 52(3): pp 227-235. [Res] SRI
  3. Malkin D, Chilton-MacNeill S, Meister LA, Sexsmith E, Diller L, Garcea RL: Tissue-specific expression of SV40 in tumors associated with the Li-Fraumeni syndrome. Oncogene 2001: 20(33): pp 4441-4449. [Res] SRI
  4. Wyatt-Ashmead J, Kleinschmidt-DeMasters B, Mierau GW, Malkin D, Orsini E, Foreman NK, McGavran L: Choroid plexus carcinomas and rhabdoid tumors: phenotypic and genotypic overlap. Pediatric and Developmental Pathology 2001: 4(6): pp 545-549. [Res] C
  5. Barrera M, Wayland LA, Mammon D'Agostino N, Gibson J, Weksberg R, Malkin D: Developmental differences in psychological adjustment and health-related quality of life in pediatric cancer patients. Children's Health Care 2003: 32(3): pp 215-231. [Res] SRI
  6. Malkin D. Predictive genetic testing for childhood cancer: taking the road less traveled by. J Pediat Hematol Oncol 2004; 26 (9): 546-548. [Res Rev] SRI
  7. Barrera M, D’Agostino N, Gibson J, Gilbert T, Weksberg R, Malkin D. Predictors and mediators of psychological adjustment in mothers of children newly diagnosed with cancer. Psycho-oncology 2004; 13: 630-641. [Res] SRI
  8. Strahm B, Malkin D. Hereditary cancer predisposition in children: molecular basis and clinical implications. International J Cancer 2006: 119: 2001-2006. [Res] SRI
  9. Travis LB, RabkinCS, Brown LM, Allan JM, Alter BP, Ambrosome CB, Begg CB, Caporaso N, Chanock S, DeMichele A, Figg WD, Gospodarowicz MK, Hall EJ, Hisada M, Inskip P, Kleinerman R, Little JB, Malkin D, Ng AK, Offitt K, Pui C-H, Robison LL, Rothman N, Shields PG, Strong L, Taniguchi T, Tucker MA, Greene MH. Cancer survivorship – genetic susceptibility and second primary cancers: research strategies and recommendations. J National Cancer Inst 2006; 98 (1): 15-25. [Res] C
  10. Tabori U, Lees J, Druker H, Nanda S, Malkin D. Telomere shortening and early cancer development in Li-Fraumeni syndrome. Cancer Research 2007 67(4): 1415-1418.[Featured Article]. [Res] SRI
  11. Tabori U, Malkin D. Risk stratification in cancer predisposition syndromes: Lessons learned from novel molecular developments in Li-Fraumeni syndrome. Cancer Res 68(7): 2053-2057, 2008. [Res] SRI
  12. Shlien A, Tabori U, Marshall C, Pienkowska M, Feuk L, Novokmet A, Nanda S, Druker H, Scherer S, Malkin D. Excessive germline copy number variation in the Li-Fraumeni cancer predisposition syndrome. PNAS. 2008; Vol. 05. No. 32: 11264–11269.
  13. Gupta A, Malkin D. Sarcomas and cancer predisposition syndromes. The Electronic Sarcoma Update Newsletter (ESUN) 2008 [in press] [Res, E] SRI